Mike De Angelis




Mike is a shareholder in the Firm’s Corporate practice group.

His practice focuses on the representation of both public and private companies. His transactional experience includes:

  • Venture capital financings;
  • Mergers, acquisitions and spinoffs; and
  • Public offerings of securities.

In addition to his transaction-based experience, Mike has counseled clients on (i) 1934 Act reporting obligations; (ii) Section 16 and insider trading compliance; (iii) resales of restricted securities under Rules 144, 145, and 701; and (iv) intellectual property issues and equity compensation matters.

Mike was a corporate and securities attorney at a major Bay Area law firm before joining the firm.

State Bar of California, Business Law and Intellectual Property Law Section

Sacramento County Bar Association, Business Law Section

Meritas, Sacramento


The Best Lawyers in America®, 2020-2024 (Corporate Law), 2023-2024 (Mergers and Acquisitions Law)

Sacramento Magazine’s Top Lawyers List, 2017, 2019-2021 – Securities & Corporate Finance, Business & Corporate

Sacramento Magazine’s Top Lawyers List, 2023 – Business & Corporate, Mergers & Acquisitions

J.D., University of California, Davis, 1998

B.S., University of California, Los Angeles, 1992

Weintraub Tobin Helps Grant Wishes

On June 13, Weintraub Tobin sponsored an event for Make-A-Wish Northeastern California and Northern Nevada. With over a hundred people in attendance, the event helped to raise funds to grant wishes for kids with life-threatening medical conditions. The event was held at the home of co-sponsors Chris and Jennifer Granger.…

Weintraub Tobin Raises Money for American Heart Association

For a third year in a row, Weintraub Tobin is working to raise funds for cardiovascular diseases and stroke by partaking in the American Heart Association Heart Walk on Saturday, September 21 at William Land Park. Our attorneys and staff work hard during the summer months to gear up for…

Longtime Weintraub Client, ThermoGenesis, Issued Press Release Regarding Definitive Merger Agreement

Download: Press-Release-Cesca-Merger-Final.pdf RANCHO CORDOVA AND LOS ANGELES, CA – July 16, 2013 – ThermoGenesis Corp. (NASDAQ: KOOL) (“ThermoGenesis”), a leading supplier of enabling technologies for theprocessing and storage of stem cells and other biological tissues, and TotipotentRx Corporation (“TotiRx”), a privately held California Corporation, which specializes in developing cell-basedtherapies in…